Delphinidin-3-glucoside suppresses breast carcinogenesis by inactivating the Akt/HOTAIR signaling pathway

Xiaohong Yang1, En Luo2, Xin Liu1

  • 1Department of Public Health, Chengdu Medical College, Chengdu, China.

BMC Cancer
|July 9, 2016
PubMed
Abstract

Insights

Delphinidin-3-glucoside (Dp) shows chemopreventive effects against breast cancer by down-regulating HOTAIR, a long non-coding RNA involved in cancer progression. Dp inhibits Akt activation and promotes IRF1, which suppresses HOTAIR, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Nutritional Science

Background:

  • Long non-coding RNA (lncRNA) HOTAIR is implicated in cancer progression.
  • Interferon regulatory factor-1 (IRF1) and Akt signaling pathway regulate HOTAIR.
  • Delphinidin-3-glucoside (Dp), an anthocyanin, is investigated for chemopreventive properties.

Purpose of the Study:

  • To evaluate the chemopreventive effects of Dp on breast carcinogenesis.
  • To investigate the role of the Akt/HOTAIR signaling pathway in Dp's effects.
  • To determine Dp's impact on IRF1 and HOTAIR expression.

Main Methods:

  • MCF10A cells treated with carcinogens and Dp.
  • HOTAIR expression analyzed by qRT-PCR.
  • Protein expression via western blots, immunofluorescence, and immunohistochemistry.
  • Xenografted tumor models in athymic mice.
  • ChIP-qPCR to assess IRF1 binding to the HOTAIR promoter.

Main Results:

  • Dp suppressed carcinogen-induced cell transformation, including reduced growth factor dependence and anchorage-independent growth.
  • Dp treatment significantly down-regulated HOTAIR expression in vitro and in vivo.
  • Dp inhibited xenografted tumor growth and decreased HOTAIR levels.
  • Dp repressed Akt activation, increased IRF1 expression, and enhanced IRF1 binding to the HOTAIR promoter.
  • IRF1 knockdown diminished Dp's effects on HOTAIR and its cytotoxic impact.

Conclusions:

  • Dp exhibits effective chemopreventive effects against breast carcinogenesis.
  • Down-regulation of HOTAIR is a critical mechanism in Dp's chemopreventive action.
  • The Akt/IRF1/HOTAIR pathway is a key target for Dp's therapeutic potential.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K